Clinical and genetic evaluation of thirty ovarian cancer families

American Journal of Obstetrics and Gynecology

Volumn 178, Issue 1 I, 1998, Pages 85-90

  Zweemer, R P ^a   Verheijen, R H M ^a   Gille, J J P ^a   Van Diest, P J ^a   Pals, G ^a   Menko, F H ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Familial; Genetics; Histopathology; Ovarian cancer

Indexed keywords

BRCA1 PROTEIN; BRCA2 PROTEIN;

ARTICLE; CANCER FAMILY; CANCER REGISTRY; CANCER STAGING; DISEASE CLASSIFICATION; EXON; FAMILY STUDY; FEMALE; GENE MUTATION; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; ONCOGENE; OVARY CANCER; PATIENT CODING; PRIORITY JOURNAL; STATISTICAL ANALYSIS;

EID: 0031813818     PISSN: 00029378     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9378(98)70632-5     Document Type: Article

References (24)

1. O Visser JWW Coebergh LJ Schouten Incidence of cancer in the Netherlands 1992: fourth report of the Netherlands Cancer Registry 1995 SIG Health Care Information Utrecht
2. JM Schildkraut WD Thompson Familial ovarian cancer: a population based case control study Am J Epidemiol 128 1988 456 466
3. S Greggi M Genuardi P Benedetti-Panici R Cento G Scambia G Neri Analysis of 138 consecutive ovarian cancer patients: incidence and characteristics of familial cases Gynecol Oncol 39 1990 300 304
4. J Chang I Fryatt B Ponder C Fisher ME Gore A matched control study of familial epithelial ovarian cancer: patient characteristics, response to chemotherapy and outcome Ann Oncol 6 1995 80 82
5. HT Lynch T Conway J Lynch Hereditary ovarian cancer: pedigree studies, II Cancer Genet Cytogenet 52 1991 161 183
6. SA Narod D Ford P Devilee RB Barkardottir HT Lynch SA Smith An evaluation of genetic heterogeneity in 145 breast-ovarian cancer families Am J Hum Genet 56 1995 254 264
7. DF Easton D Ford DT Bishop Breast cancer linkage consortium: breast and ovarian cancer incidence in BRCA1 mutation carriers Am J Hum Genet 56 1995 265 271
8. Y Miki J Swensen D Shattuck-Eidens PA Futreal K Harshman S Tavtigian A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1 Science 266 1994 66 71
9. R Wooster G Bignell J Lancaster Y Quirk D Ford N Collins Identification of the breast cancer susceptibility gene BRCA2 Nature 378 1995 789 792
10. A Berchuck F Cirisano JM Lancaster JM Schildkraut RW Wiseman A Futreal Role of BRCA1 mutation screening in the management of familial ovarian cancer Am J Obstet Gynecol 175 1996 738 746
11. FBL Hogervorst RS Cornelis M Bout M van Vliet JC Oosterwijk R Olmer Rapid detection of BRCA1 mutations by the protein truncation test Nature Genet 10 1995 208 212
12. T Katagiri M Emi I Ito K Kobayashi M Yoshimoto S Watanabe Mutations in the BRCA1 gene in Japanese breast cancer patients Hum Mutat 7 1996 334 339
13. D Shattuck-Eidens M McClure J Simard F Labrie S Narod F Couch A collaborative survey of 80 mutations in the BRCA1 breast and ovarian cancer susceptibility gene: implications for presymptomatic testing and screening JAMA 273 1995 535 541
14. CM Phelan JM Lancaster P Tonin C Gumbs C Cochran R Carter Mutation analysis of the BRCA2 gene in 49 site-specific breast cancer families Nature Genet 13 1996 120 122
15. FJ Couch ML DeShano MA Blackwood K Calzone J Stopfer L Campeau BRCA1 mutations in women attending clinics that evaluate the risk of breast cancer N Engl J Med 336 1997 1409 1415
16. T Peelen M van Vliet A Petrij-Bosch R Mieremet C Szabo AMW van den Ouweland A high proportion of novel mutations in BRCA1 with strong founder effects among Dutch and Belgian hereditary breast and ovarian cancer families Am J Hum Genet 60 1997 1041 1049
17. A Schatzkin A Goldstein LS Freedman What does it mean to be a cancer gene carrier?: problems in establishing causality from the molecular genetics of cancer J Natl Cancer Institute 87 1995 1126 1130
18. O Serova M Montagna D Torchard S Narod P Tonin B Sylla A high incidence of BRCA1 mutations in 20 breast ovarian cancer families Am J Hum Genet 58 1996 42 51
19. CM Phelan TR Rebbeck BL Weber P Devilee MH Ruttledge HT Lynch Ovarian cancer risk in BRCA1 carriers is modified by the HRAS1 variable number of tandem repeat (VNTR) locus Nature Genet 12 1996 309 311
20. SA Narod D Goldgar L Cannon-Albright B Weber R Moslehi E Ives Risk modifiers in carriers of BRCA1 mutations Int J Cancer 64 1995 394 398
21. SA Narod L Madlenski L Bradley D Cole P Tonin B Rosen Hereditary and familial ovarian cancer in southern Ontario Cancer 74 1994 2341 2346
22. C Bewtra P Watson T Conway C Read-Hippee HT Lynch Hereditary ovarian cancer: a clinicopathological study Int J Gynecol Pathol 11 1992 180 187
23. SC Rubin I Benjamin K Behbakht H Takahashi MA Morgan VA LiVolsi Clinical and pathological features of ovarian cancer in women with germ-line mutations of BRCA1 N Engl J Med 335 1996 1413 1416
24. KA Foster P Harrington J Kerr P Russell RA DiCioccio IV Scott Somatic and germline mutations of the BRCA2 gene in sporadic ovarian cancer Cancer Res 56 1996 3622 3625